BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ismail SA, Cuadros DF, Benova L. Hepatitis B in Egypt: A cross-sectional analysis of prevalence and risk factors for active infection from a nationwide survey. Liver Int 2017;37:1814-22. [PMID: 28481452 DOI: 10.1111/liv.13469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Dahab AA, Youssef MM, Eid HM, Elsadi KW. Reporting the Undiagnosed Cases of Hepatitis B and Hepatitis C Viruses among Patients Undergoing Elective Eye Surgery in a Specialized Eye Hospital in Egypt. J Ophthalmol 2019;2019:3985865. [PMID: 31341650 DOI: 10.1155/2019/3985865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Mahmoud RH, Hefzy EM, Shaker OG, Ahmed TI, Abdelghaffar NK, Hassan EA, Ibrahim AA, Ali DY, Mohamed MM, Abdelaleem OO. GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients. Sci Rep 2021;11:20014. [PMID: 34625583 DOI: 10.1038/s41598-021-99345-2] [Reference Citation Analysis]
3 Hefzy EM, Hassuna NA, Shaker OG, Masoud M, Abelhameed TA, Ahmed TI, Hemeda NF, Abdelhakeem MA, Mahmoud RH. miR-155 T/A (rs767649) and miR-146a A/G (rs57095329) single nucleotide polymorphisms as risk factors for chronic hepatitis B virus infection among Egyptian patients. PLoS One 2021;16:e0256724. [PMID: 34437653 DOI: 10.1371/journal.pone.0256724] [Reference Citation Analysis]
4 Motawi TK, Mady AE, Shaheen S, Elshenawy SZ, Talaat RM, Rizk SM. Genetic variation in microRNA-100 (miR-100) rs1834306 T/C associated with Hepatitis B virus (HBV) infection: Correlation with expression level. Infect Genet Evol 2019;73:444-9. [PMID: 31176032 DOI: 10.1016/j.meegid.2019.06.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 El-Mokhtar MA, Hetta HF, Mekky MA, Abd El-Kareem DM, Ramadan M, Salah M, Mohamed NA, El-Masry EA, Adel S, Sayed IM. Characterization of Antigen Escape Mutations in Chronic HBV-Infected Patients in Upper Egypt. Infect Drug Resist 2021;14:2419-27. [PMID: 34234472 DOI: 10.2147/IDR.S315299] [Reference Citation Analysis]
6 Mahmoud HK, Fathy GM, Elhaddad A, Fahmy OA, Abdel-Mooti M, Abdelfattah R, Bokhary M. Hematopoietic Stem Cell Transplantation in Egypt: Challenges and Opportunities. Mediterr J Hematol Infect Dis 2020;12:e2020023. [PMID: 32395212 DOI: 10.4084/MJHID.2020.023] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Raziky MESE, Zayed NA, Ibrahim YS, Elrashdy F, Shahin RMH, Hassany M, Serafy ME, Doss W, Uversky VN, Yosry A, Eldeen HG. Association Analysis of Genetic Variants of Sodium Taurocholate Co-Transporting Polypeptide NTCP Gene (SLC10A1) and HBV Infection Status in a Cohort of Egyptian Patients. Gastroenterology Insights 2021;12:384-93. [DOI: 10.3390/gastroent12040037] [Reference Citation Analysis]
8 Liu CJ, Chen PJ. Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV. Liver Int 2021. [PMID: 34402183 DOI: 10.1111/liv.15040] [Reference Citation Analysis]
9 Madihi S, Syed H, Lazar F, Zyad A, Benani A. A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries. Biomed Res Int 2020;2020:7027169. [PMID: 32626758 DOI: 10.1155/2020/7027169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Seed CR, Allain J, Lozano M, Laperche S, Gallian P, Gross S, Kwon S, Oh E, Kim J, Chua SS, Lam S, Ang AL, Tsoi W, Hewitt PE, Davison KL, Tettmar K, O'flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio P, Carminato P, Fearon M, O'brien SF, Delage G, Kiely P, Hoad V, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, El Ekiaby M, Vermeulen M, Levičnik Stezinar S, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Seifried E, Schmidt M. International Forum on Occult hepatitis B infection and transfusion safety. Vox Sang 2019;114:e1-e35. [DOI: 10.1111/vox.12743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Shiha G, Soliman R, Mikhail NNH, Easterbrook P. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages. J Hepatol. 2020;72:658-669. [PMID: 31734097 DOI: 10.1016/j.jhep.2019.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
12 Abdelbary MS, Samir R, El-nahaas SM, Hosny Shahin RM, El-sayed M, Gaber Y, Tantawi O, Zayed NA, Yosry A. Hepatitis B reactivation following eradication of HCV with direct-acting antiviral drugs (DAAs) in a cohort of patients from different institutions in Egypt. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.04.020] [Reference Citation Analysis]
13 El Kassas M, Shimakawa Y, Ali-Eldin Z, Funk AL, Wifi MN, Zaky S, El-Raey F, Esmat G, Fontanet A. Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data. Liver Int 2018;38:2159-69. [PMID: 29738637 DOI: 10.1111/liv.13874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]